Get the Stockscreener App
1.06
0.95%
0.01
After Hours:
1.06
Polyrizon Ltd stock is traded at $1.06, with a volume of 221.91K.
It is up +0.95% in the last 24 hours and up +0.00% over the past month.
See More
Previous Close:
$1.05
Open:
$1.07
24h Volume:
221.91K
Relative Volume:
9.59
Market Cap:
$4.45M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$1.00
$1.1599
1-Week Range:
$1.00
$1.51
52-Week Range:
$1.00
$1.51
Polyrizon Ltd Stock (PLRZ) Company Profile
Polyrizon Ltd Stock (PLRZ) Latest News
Aegis Capital Corp. Acted as Sole Bookrunner on a $4.2 Million (IPO) Initial Public Offering for Polyrizon Ltd. (NASDAQ: PLRZ) - AccessWire
Polyrizon Announces Closing of $4.2 Million Initial Public Offering - The Manila Times
Polyrizon Prices 958.9K Share IPO at $4.38/unit By Investing.com - Investing.com South Africa
Polyrizon Prices 958.9K Share IPO at $4.38/unit - Investing.com India
Polyrizon Announces Pricing of $4.2 Million Initial Public Offering and Listing on the Nasdaq Capital Market Under New Ticker “PLRZ” - StockTitan
SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million - StockTitan
Israel-Based Biotech Penny Stock SciSparc Outlicenses Its Cannabinoid Pain Therapy - Benzinga
SciSparc signs exclusive patent license agreement with Polyrizon - TipRanks
SciSparc Finalizes Exclusive Global Out-Licensing Agreement for its Pain Therapy Valued at $3 million - GlobeNewswire
Polyrizon Ltd Stock (PLRZ) Financials Data
There is no financial data for Polyrizon Ltd (PLRZ). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.02%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):